+44 207 488 9947
News 2020
Testimonial: Extentuating Circumstances - November 2020
Final year student graduated in 2020 and needed a chance to repeat the final year due to extenuating circumstances - RT Coopers drafted the appeal and provided guidance as to the evidence that had to be adduced to support the case - Appeal successful - Retaking final year without having to wait until September 2021 – first published on Google My Business.
'In my final academic year I was slowly becoming lost in my anxiety and the stresses of my studies. I was unable to realise this for myself, let alone inform my university that I was struggling so much. When I was told that I would not be able to graduate, and that my last-minute applications for leniency under the circumstances had come too late, I asked Rosanna Cooper for help in appealing my case. Her dedication to my appeal, and her confidence that we would be successful was a lifeline in a very difficult time. In the end, she helped me create an incredibly detailed appeal that comprehensively demonstrated that I had been unforeseeably disadvantaged by my mental health, in a way that the university had not taken into consideration. I am now retaking my third year, after the success of my appeal. Rosanna has given me a second chance to prove myself, and to get the support I did not realise I needed at the time. I would definitely recommend her if you need help with an academic appeal, as she will fight in your corner as hard as she can!' Daniel Johnson
More
Diseases - November 2020
Elite multidisciplinary team
advising on regulatory and
legal issues in relation to
diseases
Our phenomenal diseases team will advise and assist your biopharma company engaged in the research & development, diagnosis, treatment, manufacturing and supply of medicines for diseases. Our outstanding diseases team comprises lawyers, scientists and regulatory experts with knowledge and insight into the life sciences and pharmaceuticals sectors. Our diseases team also comprises scientists with doctorates and postdocs who have first-hand experience conducting research as well as working in the pharmaceutical, biotechnology and life sciences industry sectors. Accordingly, our highly skilled multidisciplinary legal and regulatory diseases team has great insight into the legal and regulatory landscape applicable to diseases and the demand for new drug discovery.
Our diseases lawyers will advise and assist you whether you are a pharmaceutical, a small and medium biotechnology or IT company involved in the diagnosis, treatment, manufacture and supply of medicines and vaccines for diseases.
Testimonial: Academic Misconduct - September 2020
First year student studying for a degree in Mathematics with Management and Finance was accused of collusion by a University during open book exams. Like most students during lockdown, the lecturers did not get a chance to complete the modules. There were irregularities surrounding the exam papers for these modules and the University did not have clear procedures, regulations or policies in relation to sitting open book exams. During the lockdown period, the student sought answers from a chatroom (specifically about the irregularities pertaining to these exam papers). The basis for the allegation of collusion was that there were other students sharing information about the exams in the chatroom and this amounted to collusion as the student could have and must have seen the questions and answers that were being circulated. Clearly, the allegations were false and with damaging consequences for the student if found guilty of collusion. The student was put under tremendous pressure to accept the allegation of collusion. RT Coopers advised the student to deny the allegation and drafted the appeal and represented the student at the hearing. The University gave the student a warning (with no justification) although the panel stated that this would be removed from the student’s records at the end of the course. The student was satisfied with this outcome as a number of other students were in the chatroom at the same time had been accused and found guilty of collusion, given harsher penalties with no means of removing the offence from their records. This was a very difficult case for both sides in particular as the University was trying to clamp down on students' using chatrooms during open book exams without having any regulations or policies to deal with the issues. Clearly, a good outcome for the student. We applaud the student for taking a stance against the University and ensuring that the penalty was a warning with no impact on the student’s future.
'I was wrongly accused of collusion by my university. I was about to give up on my case, as other solicitors said that they cannot win my case, when Rosanna Cooper contacted me and said that we can win. We managed to reduce penalty of collusion to just warning. Rosanna helped me to prepare written submission and was very supportive during the misconduct meeting and after. I’m very happy with the work and I would highly recommend RT Coopers. 5 stars.' AY
More
Chronic Disease - September 2020
Leading chronic diseases team
advising and assisting pharma
and biotechnology companies
in the research & development,
diagnosis, treatment, manufacturing
and supply of medicines for chronic
diseases.
Our chronic diseases team will advise and assist your company during the development of new medicines and vaccines to combat the growing threat of chronic diseases, the development of new delivery models and the application of genomics to develop medicines. A chronic diseases lawyer will provide you with legal advice if you are conducting innovative research into the prevention and control of chronic diseases. Our chronic diseases team is experienced in advising the biopharmaceutical sector and is able to provide you with expert legal services pertaining to the development of new models to manage chronic diseases, the development and use of apps and Artificial Intelligence (AI) solutions to the monitoring, treatment and management of chronic diseases.
Our diseases team comprises scientists with doctorates and postdocs who have first-hand experience conducting research as well as working in the pharmaceutical, biotechnology and life sciences industry sectors. Accordingly, our highly skilled multidisciplinary legal and regulatory chronic diseases team has great insight into the legal and regulatory landscape applicable to chronic diseases and the demand for new drug discovery.
Testimonial - Redundancy - Settlement Agreement - August 2020
Redundancy - RT Coopers assisted in the negotiation of Redundancy Package which was favourable - Advised on the Terms and Implications of a Settlement Agreement
'Big thanks to RT Coopers for the excellent work they have done dealing with my settlement agreement recently. This was a first for me and I did not know what to expect in terms of the process and outcome. Their approach was very thorough and I was also made aware of costs before and during our collaboration. Communication was clear at any stage and was not affected by the 'new normal' of the Covid-19 pandemic. Rosanna's advice was crucial and helped me to decide course of action and reach an outcome that was the best under the circumstances. I would give RT Coopers a 5-star rating'. SH
Infectious Disease - July 2020
Expert infectious diseases
team advising on regulatory
matters in connection with
infectious diseases.
Our outstanding infectious diseases team comprises lawyers, scientists and regulatory experts with knowledge and insight into the life sciences and pharmaceuticals sectors. We will advise and assist you whether you are a pharmaceutical, a small and medium biotechnology or IT company involved in the diagnosis, treatment, manufacture and supply of medicines and vaccines for infectious diseases.
More
Rare Diseases - July 2020
Leading rare diseases team 
advising and assisting pharma
and biotechnology companies
in the research & development,
diagnosis, treatment, manufacturing
and supply of medicines for rare
diseases.
The outstanding rare diseases lawyers at our law firm are experts in life sciences and pharmaceuticals law. A lawyer specialising in rare diseases will advise and assist you whether you are a pharmaceutical, a small and medium biotechnology or IT company involved in the diagnosis, treatment, manufacturing and supply of medicines for rare diseases. The rare diseases team at RT Coopers comprises scientists with first-hand experience of conducting research as well as working in the pharmaceutical and biopharmaceutical industry sectors. Therefore, our law firm has assembled a rare diseases team that appreciates that there are many conditions with currently no treatment and that there is still a lack of epidemiological, clinical and health economics data for most rare diseases. There is clearly reduced access to rare diseases medicines such as orphan drugs because of the lack of relevant knowledge, expertise and treatment for rare diseases limited patient numbers.
Rare diseases are defined as diseases with a particularly low prevalence affecting the lives of individual. In the UK alone this is as high as 3 million people. Hence, the diagnosis and treatment of rare diseases is a global issue requiring cross border strategic partnerships to ensure the continuing development of new medicines to treat these diseases.
More
Innovative Medicines - July 2020
Leading innovative medicines
team advising pharmaceutical
compnies on the legal and
regulatory issues surrounding
the development and delivery
of innovative medicines.
Our team of innovative medicines lawyers are at the cutting edge of the legal and regulatory issues facing organisations using AI, emerging technologies and software with the aim of shortening the developmental cycle of certain medicines involved in the groundbreaking development of next generation medicines. There are a number of challenges facing pharmaceutical companies conducting research and development as well as the delivery and supply of an innovative medicine and we have assembled a team comprising life sciences and pharmaceutical lawyers and industry led experts who are well placed to advise and assist from the research & development stage to the delivery and supply of your innovative medicines.
Antimicrobial Resistance Practice Area - June 2020
Elite antimicrobial 
resistance lawyers
advising on the legal
and regulatory aspects
of R&D to the supply
of novel antimicrobial
medicines and vaccines
Our leading antimicrobial resistance lawyers will advise and assist you with your initiatives to develop, manufacture and supply antimicrobial medicines. The antimicrobial resistance team at RT Coopers comprise scientists with first-hand experience of conducting research as well as working in the pharmaceutical and biopharmaceutical industry sector. Our antimicrobial resistance team is well placed to guide you on legal and regulatory issues that may arise during the development of novel antimicrobial medicines and vaccines aimed at limiting resistance or reducing the emergence and spread of antimicrobial resistance.
Antimicrobial resistance occurs when microbes evolve to become more or fully resistant to antimicrobials which previously could treat them such as antibiotics. As pathogens become resistant to antimicrobials the chances of treating infections are substantially reduced. Our AMR team is cognisant of the urgent threat of antimicrobial resistance, posed by the emerging and steady increase of microbes that are resistant to antimicrobial treatments including the threat to the effective treatment of infectious diseases. Accordingly, our antimicrobial resistance lawyers have the knowledge and expertise to advise and assist you and to provide the highest quality legal and regulatory advice whether you are a research-based pharmaceutical company or a biotechnology company; once you are involved in the development of innovative new medicines, new diagnostic tests and/or utilising antibacterial clinical development.
More
Clinical Trials Practice Area - June 2020
Leading clinical trial lawyers 
along with clinical research
experts from pharma and life
sciences industry sectors,
advising on the legal and
regulatory aspects of your
clinical trials.
Our elite clinical trials team has first-hand experience of conducting and evaluating applications for clinical trials required to test new treatments in a broad range of clinical research in the pharmaceutical and biopharmaceutical industry. The trials team comprise lawyers with doctorates and post doctorates as well as scientists with doctorates and post doctorates. A member of the clinical trials team will advise and assist you if you are planning to bring new drugs, biotechnology products or medical devices to market and are conducting or intend to conduct medical research studies, in particular, in the development of new medicinal products, vaccines and diagnostic products for diseases.
In addition, our clinical trials lawyers have phenomenal expertise in advising on clinical research involving the use of existing medicinal products, testing the efficacy and reduction of certain side effects of existing medicines and disease prevention.
Testimonial: Antibacterial/Antiviral Product- June 2020
Advanced Formulations (Europe) Ltd
'The firm helped us through a scientific and regulatory issue raised by the HSE and we were poorly equipped to respond to the authority, prior to your firm’s efforts. Our overall impression of RT Coopers is that the firm is professional. The biocidal lawyers conducted a conscientious review of our issues and we got precise responses which we needed. The legal commentary on our issues helped us to respond to the authorities with confidence. The Report prepared by the firm was extremely detailed and enabled us to respond to the HSE where their follow up questions were minimal'. Sean-Robbie Campbell, Chief Executive Officer, Advanced Formulations (Europe) Ltd
More
CBD - JUne 2020
Our elite regulatory lawyers 
experts in the manufacture,
classification,are leading
sale, supply and distribution
of Cannabidiol Products
Our CBD regulatory lawyers will advise and assist you with the manufacture, classification, sale, supply and distribution of your Cannabidiol ('CBD') products for medicinal purposes. In the United Kingdom ('UK'), products containing CBD Oil are classed as medicines if they are used for medicinal purposes and are sometimes referred to as 'Medical Cannabis'. Our outstanding pharma and regulatory lawyers have the expertise to advise and assist you with the classification, labelling, packaging and licensing of your CBD products. All products used for medical purposes that contain CBD must possess marketing authorisations before the CBD products can legally be sold, supplied or distributed i.e before they can be placed on the UK market. Manufacturers of CBD products must demonstrate that their CBD products meet the requisite safety, quality, efficacy and effectiveness standards. Our regulatory solicitors will guide you on the regulatory processes and requirements for the cultivation of low tetrahydrocannabinol (“THC”) or varieties of Cannabis Sativa ('Hemp').
Testimonial: Settlement Agreement- May 2020
Voluntary Redundancy - Settlement Agreement Advice
'Thank you for all your hard work and assistance with my case.This was a 1st for me which I can only say was a breeze.
Definitely 5 stars for your service, professionalism and delivery. I would 100% recommend yourself to anyone I know. Thank you again. LB
Agrochemicals Practice Area - May 2020
Leading intellectual property
and agrochemical lawyers
providing advice and assistance
to the agrochemical sector
Our agrochemical lawyers draw on our expertise in intellectual property (IP) law, corporate and commercial law as well as regulatory law in advising agrochemical companies on the IP, commercial and regulatory issues pertaining to agrochemicals or crop protection products. Our agrochemcial solicitors will provide legal advice to your agrochemical company on a range of legal issues in relation to agrochemicals, including:
- Research and development
- IP protection
- Importation
- Labelling
- Licensing
- Packaging
- Regulatory compliance
- Supply chain
- Supply and distribution. .
The term agrochemicals refer to pesticide chemicals such as insecticides, pesticides, herbicides, fungicides and seed treatment. Pesticides include plant protection products and biocides
Testimonial: Settlement Agreement- May 2020
Voluntary Redundancy - Settlement Agreement Advice
'I am so pleased with the services provided by RT Coopers. I would rate this company 5 out of 5 for the whole experience.
From the minute I contacted them Rosanna was very prompt with her responses and showed me amazing support during a time where I needed a legal understanding about things I had very little knowledge of.
Rosanna was so approachable and made everything clear and understandable in a way that guided me to a happy resolution.
This was specifically relevant when we had a lengthy audio call going through a settlement agreement and each point was explained me concisely so I was able to be clear about my decision and any associated causes. It was actually a really comfortable conversation which put me completely at ease.
I have personally benefited from RT Coopers legal support and would recommend them to anyone seeking advice. They were able to challenge some areas of my agreement that were not suited to my individual needs and make changes that provided me with the correct outcome. I have never had to seek legal advice before so was nervous to do so but felt completely reassured with the support offered during this new and unique situation.
I am very grateful for their help and thank Rosanna in particular for her constant updates and guidance'. JY
Plant Protection Products - May 2020
A leading plant protection products lawyer will be on hand to advise and assist your company through the regulatory process required for the approval of the active substance in your pesticides (‘Plant Protection Products’ ‘PPP’), authorisation, registration, placing your PPP on the market, use and control of your PPP. Your Plant Protection Products may be chemical or biological substances used in agriculture, horticulture or in home gardens.
Plant protection products are 'pesticides' that protect crops or desirable or useful plants. A 'pesticide' is a product that prevents, destroys, or controls a harmful organism ('pest') or disease, or protects plants or plant products during production, storage and transport. The registration and use of PPPs are regulated and controlled. Pesticides include ‘control pests, weeds and diseases’ in the form of insecticides, fungicides, herbicides, molluscicides and plant growth regulators.
Testimonial May 2020
ST4 Surgical Trainee facing Outcome 4 before the ARCP Panel Meeting - RT Coopers reviewed the MSF and prepared detailed response in conjunction with the trainee doctor - RT Coopers also prepared response to the AES Report from the Educational Supervisor - Trainee given outcome 4 after ARCP Panel Hearing - Successful Outcome - First published on Google My Business
'Fantastic Law Firm. Dr. Cooper is amazing. As a young doctor, I had people trying to get me into trouble, by assigning blame. The firm is incredible. We spent 1 hour on the phone then instead of 1 day, two days preparing the case. I would go back to this firm in a flash'. Dr Ej Dimera
Settlement Agreements & Redundancy Frequently Asked Questions - May 2020
1. As An Employee, In What Circumstances Can I be Made Redundant?
An employer may only make you redundant, if the employer has genuine reasons for terminating your employment. You should only be made redundant if there is a genuine redundancy, otherwise you may be able to claim for unfair and/or wrongful dismissal. Redundancy typically involves either temporary or permanent closure of a business as a whole or closure of a particular workplace where you are employed. Additionally, you should note that redundancy can involve a legitimate reduction in the size of the workforce.
2. What Are My Employer’s Responsibilities When Contemplating Making Me Redundant?
There are a number of key guidelines that an employer must adhere to when contemplating making you redundant:
Planning
Employers are under an obligation to draw up a plan to decide which employees would be kept on or made redundant. The plan should include the selection criteria, namely detail reasons for those being kept on or made redundant.
Employers must inform you, if you are at risk of redundancy, of the impending redundancy as soon as possible to ensure that you have a chance to suggest alternatives to redundancy, apply for other jobs with the employer (where available) or apply for new jobs with other employers.
Employers should consider any proposals that you or your representatives make as an
alternative to redundancy.
Employers should decide as soon as possible how many employees would actually be made redundant.
Consultation
Employers should note that in the event that 20 or more employees are to be made redundant, the employer has a duty to consult with your representatives, including any relevant trade unions.
Employers must discuss alternatives to redundancy as well as the applied selection criteria for the redundancies..
In order to assist your company with an application, we require a clinical evaluation of the relevant scientific literature currently available relating to the safety, performance, design characteristics and intended purpose of your product in order to .assist with the application. The data needs to adequately demonstrate that the product fulfills its intended purpose.
There are further regulatory requirements if the surgical masks are sterile.
Product Types
- Gloves with ‘dual use’
- Examination Gloves
- Examination Gloves coated with an antimicrobial agent
- Stand-alone software including apps
- Sterile Surgical Gloves
- Surgical Gloves
- Surgical Gloves coated with an antimicrobial agent
- Surgical Masks
More
Furlough: Coronavirus Pandemic - April 2020
-
Coronavirus Job Retention Scheme ('Scheme’)
The UK government’s Scheme allows employers who are unable to maintain their current workforce to furlough employees and apply for a grant to cover 80% of their usual monthly wage costs, up to £2,500 a month.
According to the Government the Scheme will provide a grant to cover "the lower of 80% of an employee's regular wage or £2,500 per month, plus the associated Employer National Insurance contributions and minimum automatic enrolment employer pension contributions on that subsidised wage. Fees, commission and bonuses should not be included".
It is understood that the Scheme will cover an initial three month period from 1 March 2020, extendible by the Government if deemed necessary.
Our leading life sciences & vaccine lawyers will assist your company during the development of new vaccines or in securing marketing authorisations from the Medicines and Healthcare products Regulatory Agency (‘MHRA’), in order to manufacture and place new vaccines for infectious diseases on the market in the UK. Any new vaccines including pandemic vaccines must be approved before they can be released on the market.
Our biotechnology & vaccine lawyers have worked in the pharmaceutical and biotechnology industry in the development of vaccines and in carrying out clinical trials and can bring amazing insight to your trials if your company is designing, conducting, recording and reporting trials that involve the participation of human subjects..
Our life sciences lawyers will advise and assist your vaccine company through the regulatory process to ensure that your results (derived from the data collected during the product development and clinical trials) meet the requisite quality, efficacy and safety for new vaccines.
Our vaccine lawyers will assist with the evaluation of the clinical and non-clinical data to be submitted in your dossier in the application for marketing authorisations.
Online Pharmacy Regulation - March 2020
Our leading online pharmacy solicitors are specialists in advising online pharmacists. Our online pharmacy lawyers will apply the highest quality advice in assisting and advising you on a variety of legal and regulatory issues arising out of and/or in connection with an online pharmacy including, the setting up of an online registered pharmacy, mergers and acquisitions, supplying medicines online to patients, the provision of pharmacy services, advertising and promotions,
.Our pharma law firm draws on the expertise of its multidisciplinary team when advising you on the issues affecting your business in the pharmaceutical industry. Our specialist lawyers combine scientific knowledge and understanding of the life sciences and pharmaceutical sectors, with the elite legal experience necessary to provide creative legal and practical solutions to straightforward legal issues as well as problems arising from complex legal issues such as IP protection, regulatory and commercial law issues. Our pharma law firm in the UK, advise and assist small and medium-sized enterprises to corporate organisations on a wide range of corporate finance, IP, commercial law and regulatory matters.
Testimonial February 2020
PhD student, who had upgraded from MPhil to PhD, was writing up thesis and was withdrawn from university after 4 years of studies before getting an opportunity to complete and submit thesis. RT Coopers on reviewing the case found that the student was withdrawn from university due to serious procedural irregularities on the part of the university. A consultation (via audio) was held with the student to particularise the grounds of appeal. The student drafted and submitted a stage 1 academic appeal which was rejected by the university. RT Coopers then drafted the stage 2 academic appeal on grounds of serious procedural irregularities, the academic appeal was accepted and a hearing was constituted. RT Coopers drafted the statement for the panel hearing and prepared the student for the hearing (it was important to prepare the student for the hearing due to the number of technical points that had to be brought out during the hearing). The student was not represented at the panel hearing. It took 4 months to get a decision. During this period, RT Coopers was guiding and supporting the student as there was a battle going on between the school and the panel as it transpired that the panel had upheld the appeal and the school was resisting the decision. RT Coopers prepared arguments over the 4 months for the student to send to the university with the intent to get back to university as well as supporting and guiding the student. The university eventually conceded and the student is allowed to continue. Without the level of guidance and support from RT Coopers for the student during the last 4 months, the student would not have had this positive outcome, despite the panel upholding the appeal.
NB: It’s important to have a thorough understanding of the regulations, policies, codes of practice and procedures in order to succeed in your appeal.
'A year ago, I was in a very difficult place. I was withdrawn from the university’s course, and had just started the appeal system. I was lost and had to enter a process I barely understood. I then proceeded to contact various academic lawyers, many of whom declined. One just said (after a 15 minute discussion), “I estimate writing your appeal will be a 5-7 hour job, here’s a quote.” Then I contacted RT Cooper Solicitors, and reached Dr. Cooper. I spent an hour discussing what happened, going into depth and detail about every nook and cranny of the case. This was the beginning of many more discussions, with someone who genuinely cared about what I was going through, and was willing to work together in order to get the best possible outcome for me. Through this very long process, Dr. Cooper has always helped me, and has repeatedly gone above and beyond the call of duty. Throughout this whole ordeal, she always offered sound advice, produced stellar work and gave me a level of support I didn’t know was possible. Overall, if you are facing academic appeals, I cannot think of anybody else I would recommend. I am now able to continue my studies'. Unurtsetseg Ulaankhuu
Testimonial - January 2020
Failure of assignment - RT Coopers gave advice on grounds of academic appeal - successful outcome on appeal - first published on Google My Business
Testimonial - January 2020
Trainee Registrar in Medical Oncology Specialty (then ST4)- ARCP Outcome 3 – Drafted and submitted an Appeal of the Decision of ARCP Panel on behalf of Doctor – Following successful Appeal to the ARCP Appeal Panel the Trainee Registrar received ARCP Outcome 2 - Now Consultant
'Receiving unfair ARCP outcome (outcome 3) after my ARCP meeting was one of the darkest hours in my life. I felt helpless and in need of help. However, knowing that it was an unfair outcome, I decided to appeal.
I knew that I needed professional help to get the appeal right. Searching online, I found a few names but after deliberating, I chose Dr Rosanna Cooper of RT Coopers. I immediately felt that my intuition was right. The commitment, work-ethic and the professionalism that she embodied were instantaneously reassuring. She gave me adequate time to listen to my case and consider all its aspects before reaching the appropriate argument that nailed the case.
After submitting my appeal, my case was reviewed by the same panel that awarded the initial outcome. After reading the appeal, the panel changed the outcome to ARCP Outcome 2. The chair of the panel praised the written appeal arguments and he said, “that he agreed with a lot of its content”. Rosanna is a professional, compassionate, and savvy solicitor and it was god who sent her to me. During your difficult times, I am sure she will help you too.' Dr M.M
- Practice Area: AI & Data Science
15-12-2024 - Case Law: Churchill Case
30-11-2024 - Testimonial : Academic Misconduct
23-11-2024 - Testimonial - MPharm Student
22-09-2024 - MODERNA V. PFIZER/BIONTECH
28-08-2024 - Patents - Artificial Intelligence
05-07-2024 - Case Study : OSCE Retake
26-06-2024 - IBM vs LZLABS report by D Corbin
20-05-2024 - Case Study : Biomedical Science
14-03-2024 - Case study : MSc Nursing Student
22-02-2024 - Case Study : Accused of Plagiarism
09-11-2023 - Testimonial : MBBS Resit Failure
05-11-2023 - Case Study : MBBS Professionalism
01-11-2023 - Pre-packed Food Labelling Deadline
26-10-2023 - Case Study : MBBS withdrawal
14-10-2023
